เดกซ่าเมทาโซน (เม็ด)

• DEXAMETHASONE0.500 milligramต่อ 1 tablet

ประเภทควบคุม

ยาควบคุมพิเศษ

ข้อบ่งใช้

Neurology: Cerebral oedema caused by brain tumours, neurosurgery, bacterial meningitis, brain abscess. Pulmonary and respiratory diseases: Severe acute asthma attack. Dermatology: Oral initial treatment of extensive, severe, acute skin diseases that respond to glucocorticoids, such as erythroderma, pemphigus vulgaris, acute eczema. Autoimmune disorders/rheumatology: Oral initial treatment of autoimmune diseases, such as systemic lupus erythematosus (especially visceral forms). Severely progressive form of active rheumatoid arthritis, e.g. rapidly destructive forms and/or with extra-articular manifestations. Infectology: Severe infections with toxic conditions (e.g. tuberculosis, typhoid) only with concomitant anti-infective therapy. Oncology: Palliative treatment of malignant tumours. Endocrinology: Congenital adrenogenital syndrome in adulthood. COVID-19: Dexamethasone is indicated in the treatment of coronavirus disease 2019 (COVID- 19) in adult and adolescent patients (aged 12 years and older with body weight at least 40 kg) who require supplemental oxygen therapy.

รหัส ATC

H02AB02 (DEXAMETHASONE - Admin route (O))

ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ